Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300073319Phase 4Not yet recruiting
Phase 4 trial of esketamine, midazolam and remimazolam in postoperative pain (3 arms), sponsored by Second Affiliated Hospital of Zunyi Medical University. Primary endpoints: Sedation-restlessness score, Pain score and 1 more. Planned start Jul 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300073319.